๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of HPV infection on the clinical outcome of p-CAIR trial in head and neck cancer

โœ Scribed by Miroslaw Snietura; Wojciech Piglowski; Magdalena Jaworska; Anna Mucha-Malecka; Grzegorz Wozniak; Dariusz Lange; Rafal Suwinski

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
268 KB
Volume
268
Category
Article
ISSN
0302-9530

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Impact of nutrition on outcome: A prospe
Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy
โœ Paula Ravasco; Isabel Monteiro-Grillo; Pedro Marques Vidal; Maria Ermelinda Cami ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 545 KB

## Background: We aimed to determine the effect of dietary counseling or oral supplements on outcome for patients with cancer, specifically, nutritional outcome, morbidity, and quality of life (qol), during and 3 months after radiotherapy. ## Methods: Seventy-five patients with head and neck canc

The clinical implications of antitumor i
The clinical implications of antitumor immunity in head and neck cancer
โœ Clint T. Allen; Nancy P. Judd; Jack D. Bui; Ravindra Uppaluri ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 319 KB

## Abstract Recent developments have renewed interest in understanding the interaction between transformed cells and the immune system in the tumor microenvironment. Here, we provide a comprehensive review addressing the basics of tumor immunology in relation to head and neck cancer and the cellula

The application of a two-stage design fo
The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer
โœ Eisenberger, Mario A. ;Ellenberg, Susan ;Leyland-Jones, Brian ;Friedman, Michael ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 620 KB

Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this